LIMN
Liminatus Pharma·NASDAQ
--
--(--)
--
--(--)
1.00 / 10
Underperform
Technical assessment is poor, scoring 1.0/10 (Underperform). Both Long Lower Shadow and Long Upper Shadow patterns signal bearish pressure, with no bullish indicators observed in the last five days. The chart suggests heightened downside risk.
Analysis Checks(0/2)
Long Lower Shadow
Score1/10
Win Rate31.46%
Hist. Signals89
Avg Return1.09%
Score1/10
Win Rate31.46%
Hist. Signals89
Avg Return1.09%
Long Upper Shadow
Score1/10
Win Rate33.33%
Hist. Signals102
Avg Return-1.78%
Score1/10
Win Rate33.33%
Hist. Signals102
Avg Return-1.78%
Long Lower Shadow
Score1/10
Win Rate31.46%
Hist. Signals89
Avg Return1.09%
Score1/10
Win Rate31.46%
Hist. Signals89
Avg Return1.09%
Long Upper Shadow
Score1/10
Win Rate33.33%
Hist. Signals102
Avg Return-1.78%
Score1/10
Win Rate33.33%
Hist. Signals102
Avg Return-1.78%
What is the current technical signals for LIMN?
- LIMN presents a Underperform setup with a Technical Score of 1.00/10. Key technical indicators highlight an RSI of 35.34 and a MACD of 0.03, with the trend anchored by the 50-Day SMA at 0.47. Traders should monitor key support at 0.17 and resistance at 0.18.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
